22 Mar 2018 - 23 Mar 2018
Kymab's Director of Pharmacology and Translational Sciences, Richard Sainson will be presenting at the Mastering Immunity Europe 2018 conference
As targeted immune therapies grow in complexity, understanding and controlling immune regulation has never been more important in the design of therapeutics.
Join experts in both academic and commercial immunology at Mastering Immunity Europe 2018 for a focussed conference to learn the latest developments in this fast-developing field covering multiple aspects of in the development of modern therapeutics. This focussed meeting is a forum for key people involved in wanting to characterize immune modulation following delivery of biologics and other therapies to come together to share knowledge, perspectives and discuss solutions to the complex challenges of immunity in this context. They will focus on manipulation and characterization of both desired (in immuno-oncology and vaccines) as well as unwanted immune responses (i.e. immunogenicity to biotherapeutics or viral vectors).